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Abstract
Objective: MicroRNAs (miRNAs) are a class of small non-coding RNAs that play pivotal 
roles in many biological processes such as regulating skeletal muscle development where 
alterations in miRNA expression are reported during myogenesis. In this study, we aimed 
to investigate the impact of predicted miRNAs and their target genes on the myoblast to 
myocyte differentiation process. 
Materials and Methods: This experimental study was conducted on the C2C12 cell line. 
Using a bioinformatics approach, miR-214 and miR-135 were selected according to their 
targets as potential factors in myoblast to myocyte differentiation induced by 3% horse 
serum. Immunocytochemistry (ICC) was undertaken to confirm the differentiation process 
and quantitative real-time polymerase chain reaction (PCR) to determine the expression 
level of miRNAs and their targets.        
Results: During myoblast to myocyte differentiation, miR-214 was significantly down-
regulated while miRNA-135, Irs2, Akt2 and Insr were overexpressed during the process.     
Conclusion: miR-214 and miR-135 are potential regulators of myogenesis and are 
involved in skeletal muscle development through regulating the IRS/PI3K pathway.   
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Introduction
Several global approaches have been applied in 
order to better understand the molecular mecha-
nism of myogenesis. Skeletal muscle is derived 
from the somites, the embryonic structures in mam-
malians that produce differentiated muscular tissue 
after progressive subdivisions (1). Myoblasts (im-
mature muscle cells) exit from cell cycle after a de-
fined proliferation time to then become terminally 
differentiated myocytes (1, 2). Finding the protein 
network underlying skeletal muscle differentiation 
will lead to a better understanding of muscle biol-
ogy, muscle dysfunction and pathogenesis of vari-
ous muscular disorders, and may provide new ap-
proaches for therapy.
The fate of myogenic precursor cells is first de-
termined by transcription factors Pax3/Pax7, fol-
lowed by regulation of myogenic differentiation 
(MyoD) through the expression of myogenic regu-
latory factors (MRFs) in the skeletal muscle line-
age (3). MyoD is thus considered as a marker of 
terminal commitment to muscle fate. Muscle-spe-
cific genes, including myosin heavy chain (MHC) 
genes, are expressed in the last phase of this multi-
regulated program, where mononucleated myo-
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cytes specifically fuse to each other to form multi-
nucleated myotubes (4). Table 1 provides the most 
important transcription factors, growth factors and 
related signaling pathways involved in muscle dif-
ferentiation.
This myogenic process is controlled by nu-
merous signaling pathways (5). In recent years, 
the mammalian target of rapamycin (mTOR) has 
emerged as a key regulator of skeletal myogen-
esis by controlling multiple stages of myogenic 
differentiation through distinct mechanisms (6). 
mTOR is a Ser/Thr kinase that operates as an 
important regulator of cellular differentiation 
(7). Several mediators of amino acid signals 
have been reported to lie upstream of mTOR, in-
cluding its activator phosphoinositide 3-kinase 
(PI3K) (8).
mTOR signaling regulates myoblast differen-
tiation by controlling the myogenic expression 
of insulin-like growth factor (IGF) at the tran-
scriptional level via a muscle-specific enhanc-
er (9). IGFs are critically involved in skeletal 
muscle development, adult muscle regeneration 
and hypertrophy (10). In cultured myoblasts, 
growth factor deprivation initiates the differen-
tiation process, owing to the induction of IGF 
(11) and subsequent activation of the IGF- re-
ceptor (Fig.1). It then initiates an autocrine 
signaling cascade through insulin receptor sub-
strates (IRS) 1 and 2 that activate PI3K and in 
turn a major downstream pathway mediated by 
and RAC-beta serine/threonine-protein kinase 
(AKT) (12). The IGF-1/AKT/mTOR pathway 
is therefore an important regulatory component 
which controls muscle development (13). Upon 
binding to its membrane receptor (IGFR1), IGF-
1 activates both extracellular-signal-regulated 
kinases1/2 (ERK1/2) and PI3K/AKT/mTOR 
pathways. ERK1/2 is required for myoblast 
proliferation (14), while the PI3K/Akt/mTOR 
pathway promotes protein synthesis and is es-
sential for myotube formation through a MyoD/
follistatin pathway, which requires mTOR ki-
nase activity (13, 15). Thus, PI3K/AKT path-
way is a vital intracellular signaling mechanism 
that pivotal for muscle development (16).
The process of myogenesis is extremely com-
plex and requires a specific organization of signal-
ing molecules that regulate the expression of par-
ticular genes and miRNAs (17, 18).
Recently, microRNAs (miRNAs), a class of evo-
lutionarily conserved and small non-coding RNAs 
(19), have emerged as novel and essential regula-
tors of myogenesis (20). Mature miRNAs are 21–
25 nucleotides in length and are partially comple-
mentary to one or more mRNA molecules. Their 
main function is to down-regulate gene expression 
in a variety of manners including translational re-
pression, mRNA cleavage and de adenylation (13, 
21). Regulation of myogenic gene expression by 
miRNAs has emerged as a new level of control for 
myogenesis. For example, miRNAs can promote 
differentiation by repressing negative regulators of 
transcriptional activity or suppress it by repressing 
positive regulators. Muscle-specific miRNAs such 
as miR-1, miR-133, and miR-206 have a central 
role in myogenesis (22). Other miRNAs have also 
been implicated in muscle development, including 
miR-26a (23), miR-27b (24), miR-29 (25), miR-
125b (26), miR-155 (27), miR-128a (28) and miR-
181 (29).
Additional miRNAs have been reported to par-
ticipate in skeletal myogenesis and include miR-24 
(30), miR-378 (31), miR- 221/222 (32), miR-486 
(33), miR-208b/miR-499 (34) and miR-214 (35). 
Furthermore, several miRNAs have been demon-
strated to regulate the PI3K/AKT/mTOR pathway 
during myogenesis (33). Although an increasing 
number of miRNAs are found to function in myo-
gnenesis, knowledge about the role of individual 
miRNAs in the molecular network of muscle de-
velopment remains poorly understood and still 
mainly unknown. As a new class of regulators of 
skeletal myogenesis, miRNAs hold the potential to 
identifying novel biomarkers and developing ther-
apeutic strategies for muscular diseases. The aim 
of this study was to quantify expression changes of 
bioinformatically selected miR-214 and miR-135 
and their targets, Insulin receptor substrates (Irs2), 
RAC-beta serine/threonine-protein kinase (Akt2) 
and insulin receptor (Insr)  to better understand the 
role of miRNAs during the muscle differentiation 
process.
In our survey, by using the C2C12 myoblast cell 
line, we identified two miRNA which had signifi-
cant expression change during C2C12 differentia-
tion process.
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Table 1: Muscle-specific factors during myogenic process
DifferentiationProliferation
MRF (MyoD, MRF4, Myf5), MEF2, IGFII, 
Myogenin (MyoG), MHC, M-CK
PAX3/7, HDAC4, MEF2, IGFIMyogenic factors
mTOR/PI3K/AKT pathwayMEK/ERK pathwaySignaling pathway
Transition from proliferation to differentiation, which is accompanied by the down-regulation of Pax-7 and up-regulation of Myogenin 
and MRF-4 is dependent on both MyoD and the mTOR/PI3K/AKT pathway. MyoD and Myf5 are both considered markers of terminal com-
mitment to muscle fate. Muscle-specific genes such as myosin heavy chain genes (MHC genes) and muscle creatine kinase (M-CK) are 
expressed in the last phase of this multi-regulated program. 
AKT; RAC-beta serine/threonine-protein kinase, ERK; Extracellular-signal-regulated kinases, IGF; Insulin-like growth factor, IRS; Insulin 
receptor substrates, MEF2; Myocyte enhancer factor2, MEK; Mitogen/extracellular signal-regulated Kinase, MRF; Myogenic regulatory 
factors, mTOR; Mammalian target of rapamycin, MyoD; Myogenic differentiation, HDAC4; Histone deacetylase 4 and PI3K; Phospho-
inositide 3-kinase. 
Fig.1: Myogenesis through the IGF/AKT/mTOR pathway. IGF is thought to initiate an autocrine signaling cascade through the IGF-I 
receptor, and IRS 1 and 2 that activate PI3K and mitogen-activated protein kinases (MAPK). PI3K activates AKT, however, either 
PI3K or AKT is sufficient for myoblast differentiation and fusion. PI3K and AKT drive differentiation by increasing the transcrip-
tional activity of MyoD and activating the mTOR pathway. mTOR expression and activity increases during differentiation leading to 
an increase in the activity of its downstream target, follistatin, which prevents myostatin (the most powerful inhibitor of muscle 
growth) from executing its inhibitory effect on muscle development. AKT; RAC-beta serine/threonine-protein kinase, ERK1/2; 
Extracellular-signal-regulated kinases1/2,  IGF; Insulin-like growth factor, IRS; Insulin receptor substrates, mTOR; Mammalian 
target of rapamycin, MyoD; Myogenic differentiation,  PI3K; Phosphoinositide 3-kinase, Raf; Rapidly accelerated fibrosarcoma and 
Ras; Rat sarcoma.
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Materials and Methods
Cell culture
In our experimental study, C2C12 myoblast cell 
line was obtained from a cell bank (Stem Cells Tech-
nology Research Center, Tehran, Iran). These cells 
were cultured in growth medium [GM, Dulbecco’s 
Modified Eagle Medium, (Gibco, UK)] containing 
10% fetal bovin serum (Gibco, UK) 24 hours before 
being induced to differentiate, at 37˚C and 5% CO2. 
When cell density reached 70%, cells were digested 
with 0.25% trypsin (Gibco, UK) and then seeded into 
culture dishes. When inducing C2C12 myoblasts to 
differentiate, cell density must reach >90% prior to 
changing GM to differentiation medium [DM, Dul-
becco’s Modified Eagle Medium supplemented with 
3% horse serum (Gibco, UK)]. The cells were sub-
sequently incubated with DM for another 72 hours 
to undergo differentiation.  The control cell line (the 
undifferentiated C2C12 line) was cultured only in 
growth medium for the same time period. All cell cul-
tures were performed at least in triplicate. 
Immunocytochemistry (ICC)
After inducing myogenic differentiation, C2C12 
cells cultured in 12-well plates were then washed 
with phosphate-buffered saline (PBS) and fixed 
with 4% paraformaldehyde (Sigma, USA) for 15 
minutes. Triton-100 (0.5%, Sigma, USA) was used 
for permeabilization. The cells were then blocked 
in 2% goat serum (diluted in PBS, Sigma, USA). 
After blocking, the cells were incubated with anti-
Pax7 or anti-myosin primary antibody depending 
on cell type (Sigma, USA) at 37˚C for 1 hour and 
then with the secondary fluorescent antibodies 
(Ray Biothech, USA) at 37˚C for 1 hour. The nu-
clei were stained with 4΄, 6-diamidino-2-phenylin-
dole (DAPI, Invitrogen, USA) for 30 seconds.
Bioinformatics-based microRNA selection
Using Target Scan 6.2 (36), miRWalk (37) and 
RNAhybrid (38), we generated a list of miR-214 
and miR-135 candidate target genes, containing a 
seed site for these two miRNAs. We merely chose 
target genes for each miRNA which were predict-
ed with at least two algorithms.
RNA isolation and quantitative real-time poly-
merase chain reaction (PCR)
Cells were lysed and total RNA was extracted using 
TRIzol (Invitrogen, USA) according to the manufac-
turer’s instructions. The RNA quality and concentra-
tion were estimated using denatured gel electropho-
resis and spectrophotometry respectively. About 500 
ng of the total RNA was reverse transcribed into 
cDNA using a reverse transcription kit (Fermentas, 
USA) with random hexamers for target genes. cDNA 
synthesis of miRNAs was undertaken using the Re-
verse Transcription System Kit (Promega, USA) with 
miR-specific stem-loop primers (Table 2). Quantita-
tive real-time polymerase chain reaction (PCR) was 
performed in triplicate using a 40 cycle PCR in Ro-
tor-gene Q real-time analyzer (Corbett, Sydney, Aus-
tralia). Each real-time PCR reaction contained 5 μl of 
2×SYBR Premix Dimer EraserTM (TaKaRa, Japan), 
3 pmol of forward and reverse primers respectively, 
1 μl template of cDNA and dH2O up to the final vol-
ume of 10 μl, followed by a melting curve analysis to 
confirm PCR specificity. The average threshold cycle 
was used for data analysis by Rotor-gene Q software 
(Corbett, Sydney, Australia). Gene expression levels 
were normalized against the expression of β-actin 
and Snord 47(U47) as internal controls for miRNA 
expression. The 2−ΔΔCt method was employed to es-
timate the relative expression level of each gene. 
All reactions were run in triplicate.
Comparison of real time-PCR result by a high-
throughput method data
We next assessed whether the candidate gene 
expression levels obtained by real time-PCR are 
comparable with other methods. To this end, real 
time-PCR results were compared with microarray 
data available in Gene Expression Omnibus (GEO, 
accession #GSE4694) (39).
Statistical analysis
The data were presented as mean ± standard er-
ror. To determine statistical significance, Student’s 
t test was applied. If not indicated otherwise, the 
criterion for significance was set at P<0.05. 
Results
Bioinformatically predicted targets
To bioinformatically predict target genes, we 
initially found that miR-214 and miR-135 targeted 
several signal molecules regulating the myogen-
esis process and insulin pathway such as IRS2, 
AKT2 and INSR (Fig.2).
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5ˊGTCGTATGCAGAGCAGGGTCCGAGGTATTCGCACTGCATACGACTCACA 3ˊmiR 135a- stem-loop
 Real time PCR
 Forward : 5ˊGCACAGCAGGCACAGAC3ˊ   miR- 214
Reverse : 5ˊGAGCAGGGTCCGAGGT3ˊ 
Forward : 5ˊCGATATGGCTTTTTATTCCTA3ˊmiR-135a
Reverse : 5ˊGAGCAGGGTCCGAGGT 3ˊ
Forward : 5ˊAACAGATGCCACTAATCCTTC 3ˊInsr
Reverse : 5ˊGCCCTTTGAGACAATAATCC 3ˊ 
Forward: 5ˊCAGCCAGGAGACAAGAACTC 3ˊIrs2
Reverse: 5ˊCGCTTCACTCTTTCACGAC 3ˊ 
Forward : 5ˊTTCGGCAAGGTCATTCTG 3ˊAkt2
Reverse: 5ˊTGAGGGCTGTAAGGAAGG 3ˊ 
Akt2; RAC-beta serine/threonine-protein kinase, Insr; Insulin receptor, Irs2; Insulin receptor substrates and PCR; Polymerase chain reaction.
Fig.2: Clustering of predicted targets of miRNAs. IRS2 and INSR are mutual predicted targets of both miRNAs. 
ADIPOR2; Adiponectin receptor 2, ADIPOQ; Adiponectin, AKT2; RAC-beta serine/threonine-protein kinase, INSR; Insulin receptor, IRS2; In-
sulin receptor substrate 2, Prex1; Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein and ROCK1; Rho kinase 1.
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Characterization of C2C12 differentiation
Differentiation of myoblast cells to myocytes 
was confirmed by a positive ICC result for the 
specific skeletal marker, myosin .C2C12 myoblast 
type was confirmed by a positive ICC result for the 
precursor cell marker, Pax-7 (Fig.3).
Fig.3: Myoblast to myocyte differentiation. A. Myoblast cells (a) differentiate into myocytes (b, c). Myocyte is indicated in part c and B. 
C2C12 myoblasts stained with PAX and DAPI as a positive control of precursor cells (a, b). After that, myoblasts were induced to differ-
entiate with DMEM medium containing 3% horse serum for 3 days. The differentiated cells were seeded in a new plate and stained with 
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miR-214 and -135 have different expression 
patterns during myoblast differentiation
Expression profiling of miRNAs showed that 
miR-214 and miR-135 had significantly altered 
expression during myoblast differentiation with 
miR-214 being down-regulated and miR-135 be-
ing up-regulated more than 70-fold in differenti-
ated cells (Fig.4). 
Changes in expression of predicted targets dur-
ing C2C12 differentiation
We examined the expression of Irs2, Akt2 and 
Insr as predicted targets of the two miRNAs stud-
ied. Interestingly, expression level of Irs2, Akt2 
and Insr, directly targeted by miR-214, were up-
regulated in differentiated cells (Fig.4).
Fig.4:  Expression pattern of candidate miRNAs during myoblast 
differentiation. Based on qRT-PCR results, while miR-135 was 
up-regulated miR-214 was down-regulated during the differen-
tiation process.*; P≤0.05 and qRT-PCR; Quantitative real time 
polymerase chain reaction.
Comparison of real time -PCR result with mi-
croarray data 
To extend the results of our quantitative real 
time-PCR (qRT-PCR) analysis, we analyzed all 
transcripts in an available microarray dataset. 
Chen et al. (39) had analyzed three different 
RNA samples from proliferating and differenti-
ated C2C12 cells individually (6 microarrays in 
total).
Microarray results for Insr and Akt2 reflected 
the same up-regulation trend (P value≤0.05) but 
not for Irs2 (P value=0.473, Fig.5). However, the 
magnitude of differential expression was different 
from qRT-PCR results.
Fig.5: Comparison of the expression levels of predicted targets 
during myogenesis based on qRT-PCR and microarray analysis. 
The data were consistent between the two methods except for 
Irs2 which was not shown to be differentially expressed in the 
microarray analysis (P=0.473).
Akt2; RAC-beta serine/threonine-protein kinase, Insr; Insulin re-
ceptor Irs2; Insulin receptor substrate 2 and *; P≤0.05.
Discussion
MiRNAs play important regulatory roles in 
many cell processes (40, 41) including the multi-
step differentiation process in mammalian skeletal 
muscle development (42). The regulation network 
of myogenic factors and various miRNAs is com-
plex and appears to depend on the cell cycle and 
fusion stages (43). Currently, differentially ex-
pressed miRNAs are thought to be closely related 
to almost all aspects of muscle development and 
have been shown to regulate several pathways dur-
ing myogenesis (43, 44).
Moreover, because of important similarities be-
tween embryonic muscle development and muscle 
regeneration in adults, undertaking developmen-
tal studies and particularly elucidating the roles 
of miRNAs in this multi-step process is valuable 
and may have potential clinical applications (44). 
In this study, we report that miR-135 was differ-
entially expressed and may thus be involved in 
skeletal muscle development. Our study, for the 
first time, also reports that miR-135 expression 
was up-regulated during myogenic differentiation. 
miR-135 may participate in the myocyte formation 
process through targeting unknown components 
(perhaps inhibitors of muscle growth) of myogen-
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esis in addition to those targets in our prediction 
(activators). On the contrary, we found that mature 
miR-214 was already expressed in proliferating 
C2C12 cells, however, it was significantly down-
regulated following the induction of differentia-
tion. Furthermore, our qRT-PCR analysis showed 
that expression level of Irs2, Akt2 and Insr, were 
up-regulated in differentiated cells.  The upregula-
tion of these three predicted target genes indicates 
that these genes are important in muscle differen-
tiation process.
Using an Affymetrix cDNA microarray data-
set (GEO accession #GSE4694) (39), we com-
pared the expression levels of Irs2, Akt2 and 
Insr in undifferentiated C2C12 cells with dif-
ferentiated populations. Our data were consist-
ent with those of the microarray (P≤0.05) except 
for Irs2 (P=0.473). However, qRT-PCR analysis 
revealed that the levels of Insr, Irs2 and Akt2 
transcripts were shown to be more increased in 
comparison with microarray analysis in terms of 
fold change. This discrepancy is justifiable be-
cause qRT-PCR provides a more accurate repre-
sentation of changes in the level of specific tran-
scripts than the microarray analysis. This is due 
to the linearity of qRT-PCR results over a wide 
concentration range (39, 45), as confirmed by 
serial dilution experiments with different sam-
ples (data not shown).
Decreased expression of miR-214 accompa-
nied with overexpression of Irs2, Akt2 and Insr 
in C2C12 myocytes compared with with primary 
muscle cells which underwent myogenic differen-
tiation progression.
It has been reported that muscle differentiation is 
blocked by decreased IRS-1/2 and PI3-K activity 
(3, 46, 47). Small RNAi-based gene silencing ex-
periments have shown that insulin signaling path-
ways are dependent on IRS1/2 and are required for 
myotube formation and glucose uptake through the 
activation of AKTs (46, 47). In addition, AKT pro-
motes myoblast proliferation in cooperation with 
mTOR, suggesting that IRS is a key factor in in-
ducing myoblast proliferation and myotube forma-
tion by increasing AKTs levels (47). Furthermore, 
AKT2 is associated with insulin signaling and the 
AKT/mTOR pathway which lies at the center of 
the regulatory network controlling muscle devel-
opment (28). Gene silencing has also revealed spe-
cialized roles of AKT2 in myoblast differentiation 
and glucose metabolism (46).
Interestingly, our study demonstrated that the 
down-regulation of miR-214 may accelerate myo-
genesis, because of increasing levels of its targets, 
Akt2 and Irs2, during myogenic differentiation. 
Indeed, it might be the result of increasing Irs/Akt 
activation. As an important regulator of muscle 
development, a single miRNA can regulate the ex-
pression of many mRNA targets. Identifying the 
regulatory targets of miRNAs in muscle is thus 
crucial, however, it will be more critical to place 
them in a biological pathway.
 Studies in the past were largely focused on miR-
NAs regulating a single gene in myogenic signal-
ing pathways (33-35). However, growing evidence 
suggests that miRNA can also have an effect on 
signal transduction pathways (13). By targeting a 
number of members of the same signaling path-
way, miRNA can exert more profound effects than 
regulating one individual gene in a biological pro-
cess. Thus, miR-214 down-regulation may have 
positive effects on myogenesis by overexpression 
of Akt2, Irs2 and Insr in the insulin signaling path-
way.
Conclusion
We show that miR-214 and miR-135 are poten-
tial regulators of myogenesis through regulating 
the IRS/AKT/PI3K pathway. Further studies such 
as luciferase assay and western blot and in vivo 
experience will be needed to concentrate on the 
complex regulatory roles of these miRNAs Un-
derstanding how miRNA regulate myogenesis will 
enhance our perception of the muscle development 
mechanism. Combining bioinformatics, biochemi-
cal and genetic approaches together will help us 
to elucidate the regulatory efficacy of miRNA in 
myogenesis and will also potentially establish new 
therapeutic approaches by identifying functional 
miRNA candidates as potential targets for clinical 
purposes.
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